Success Metrics

Clinical Success Rate

84.8%

Based on 78 completed trials

Completion Rate

85%(78/92)

Active Trials

21(14%)

Results Posted

46%(36 trials)

Terminated

14(9%)

Phase Distribution

Ph phase_2

31%

Ph phase_1

16%

Ph early_phase_1

Ph phase_3

23%

Ph not_applicable

Ph phase_4

21%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution149 total trials

Early Phase 1First-in-human

4(2.7%)

Phase 1Safety & dosage

24(16.1%)

Phase 2Efficacy & side effects

47(31.5%)

Phase 3Large-scale testing

34(22.8%)

Phase 4Post-market surveillance

32(21.5%)

N/ANon-phased studies

8(5.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.4%

78 of 97 finished

Non-Completion Rate

19.6%

19 ended early

Currently Active

trials recruiting

Total Trials

150

all time

Status Distribution

Active(30)

Completed(78)

Terminated(19)

Other(23)

Detailed Status

Completed78

unknown22

Recruiting18

Terminated14

Not yet recruiting8

Withdrawn5

Development Timeline

Analytics

Development Status

Total Trials

150

Active

Success Rate

84.8%

Most Advanced

Phase 4

Trials by Phase

Early Phase 14 (2.7%)

Phase 124 (16.1%)

Phase 247 (31.5%)

Phase 334 (22.8%)

Phase 432 (21.5%)

N/A8 (5.4%)

Trials by Status

suspended11%

recruiting1812%

terminated149%

unknown2215%

withdrawn53%

completed7852%

enrolling_by_invitation11%

active_not_recruiting32%

not_yet_recruiting85%

Recent Activity

21 active trials

Showing 5 of 150

active_not_recruitingphase_4

Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine

NCT05850091

terminatedphase_2

COLchicine to Prevent Sympathetic Denervation After an Acute Myocardial Infarction

NCT04420624

completedphase_3

Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

NCT04870424

not_yet_recruitingphase_2

Colchicine for Autoimmune and Subacute Thyroiditis

NCT07571681

completedphase_1

Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction

NCT05637398

View all 150 trials

Clinical Trials (150)

Showing 20 of 150 trialsScroll for more

NCT05850091Phase 4

Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine

Active Not Recruiting

NCT04420624Phase 2

COLchicine to Prevent Sympathetic Denervation After an Acute Myocardial Infarction

Terminated

NCT04870424Phase 3

Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Completed

NCT07571681Phase 2

Colchicine for Autoimmune and Subacute Thyroiditis

Not Yet Recruiting

NCT05637398Phase 1

Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction

Completed

NCT05618353Phase 4

The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial

Recruiting

NCT04381936Phase 3

Randomised Evaluation of COVID-19 Therapy

Recruiting

NCT06158698Phase 3

CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine

Recruiting

NCT06212271Early Phase 1

Mechanistic Clinical Trial of Colchicine in Patients With Peripheral Artery Disease

Completed

NCT07462325Phase 4

Proteomic and Inflammatory Omics Changes With Colchicine Therapy in Coronary Heart Disease

Not Yet Recruiting

NCT07476625Not Applicable

Efficacy and Safety of Thalidomide for Pediatric PFAPA Syndrome

Not Yet Recruiting

NCT07411768Not Applicable

Low-dose Colchicine for Thromboprophylaxis After Transcatheter Aortic Valve Replacement

Not Yet Recruiting

NCT05633810Phase 3

COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes

Recruiting

NCT05726019Phase 2

Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary Syndrome

Completed

NCT02939573Phase 2

A Randomized Multicenter Study for Isolated Skin Vasculitis

Recruiting

NCT06802926Phase 4

Pilot Trial of Colchicine for Graft Failure in CABG

Recruiting

NCT04916522Phase 2

The COlchicine HypERtENsion Trial

Active Not Recruiting

NCT07280572Phase 3

RECLAIM Adaptive Platform Trial for PCC Treatments

Enrolling By Invitation

NCT07145229Phase 2

Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

Recruiting

NCT04500665Phase 2

Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine

Recruiting

Drug Details

Intervention Type: DRUG
Total Trials: 150